Literature DB >> 30975878

Immunotherapy for neurodegeneration?

Yingjun Liu1, Adriano Aguzzi1.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 30975878     DOI： 10.1126/science.aaw0685

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  5 in total

Review 1.  Small molecules as theranostic agents in cancer immunology.

Authors:  Jindian Li; Juno Van Valkenburgh; Xingfang Hong; Peter S Conti; Xianzhong Zhang; Kai Chen
Journal:  Theranostics       Date:  2019-10-15       Impact factor: 11.556

Review 2.  A Perspective on Roles Played by Immunosenescence in the Pathobiology of Alzheimer's Disease.

Authors:  Yan Zhao; Jun-Kun Zhan; Youshuo Liu
Journal:  Aging Dis       Date:  2020-12-01       Impact factor: 6.745

3.  Anserine, HClO-scavenger, protected against cognitive decline in individuals with mild cognitive impairment.

Authors:  Nobutaka Masuoka; Chenxu Lei; Haowei Li; Noriko Inamura; Shigenobu Shiotani; Nobuya Yanai; Kenichiro Sato; Keisuke Sakurai; Tatsuhiro Hisatsune
Journal:  Aging (Albany NY)       Date:  2021-01-20       Impact factor: 5.682

4.  Dysregulation of the Adaptive Immune System in Patients With Early-Stage Parkinson Disease.

Authors:  Zhaoqi Yan; Wei Yang; Hairong Wei; Marissa N Dean; David G Standaert; Gary R Cutter; Etty N Benveniste; Hongwei Qin
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2021-07-22

5.  LAG3 is not expressed in human and murine neurons and does not modulate α-synucleinopathies.

Authors:  Marc Emmenegger; Elena De Cecco; Marian Hruska-Plochan; Timo Eninger; Matthias M Schneider; Melanie Barth; Elena Tantardini; Pierre de Rossi; Mehtap Bacioglu; Rebekah G Langston; Alice Kaganovich; Nora Bengoa-Vergniory; Andrès Gonzalez-Guerra; Merve Avar; Daniel Heinzer; Regina Reimann; Lisa M Häsler; Therese W Herling; Naunehal S Matharu; Natalie Landeck; Kelvin Luk; Ronald Melki; Philipp J Kahle; Simone Hornemann; Tuomas P J Knowles; Mark R Cookson; Magdalini Polymenidou; Mathias Jucker; Adriano Aguzzi
Journal:  EMBO Mol Med       Date:  2021-07-26       Impact factor: 12.137
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.